Vimta Labs Limited., established in 1984, is India's most comprehensive contract research and testing organization, providing wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device and many other industries. Broadly, these services include: Drug discovery, development and drug life cycle management support services in the areas like preclinical research (GLP and non-GLP), clinical research, central lab, and cGMP as well as non-GMP analytical services for pharmaceutical and biopharmaceutical companies; Preclinical research and testing services for medical device companies; Contract research and testing for Agro-science companies; Food testing and analytical development services to support manufactur ...ers, processors, farmers, retailers, traders, exporters, regulators; Clinical diagnostics services to patients, clinicians, hospitals and Environmental regulatory services such as impact assessments and post project monitoring, to industries such as infrastructure, power, cement, oil & gas, mining etc; EMI/EMC testing for electronic and electrical products.
In 1997, the Company entered into a Joint Venture with Russian Centre for Testing and Certification, ROSTEST Moscow with an investment of 24% of the total Paidup Captial. The main essence of this Joint Venture was to diversify the activities in to preshipment inspection services for all Indian exports to Russia.
During 2002, the company began to offer Clinical Diagnostics Services. Clinical Specialty Diagnostics has been an internal requirement to screen the clinical trial subjects. Facilities were created in the year 2000 to speed up the clinical trials.
During the year 2006-07, the Analytical and Clinical Reference Lab facilities was shifted from the existing Cherlapally Facility to the newly established Life Sciences Facility in S.P.Biotech Park, Genome Valley, Hyderabad which started commercial operations from September, 2006.
During the year 2020 Company acquired 100% Equity Shares of Emtac Laboratories Private Limited, on 04th March 2020, making Emtac a wholly owned subsidiary of the Company.
In 2024-25, Emtac Laboratories Pvt. Ltd., the 100% owned subsidiary got merged with the Company effective from 01 April, 2024, thereby consolidating its presence in the Electronics and Electrical testing.
Yes, you can invest in Vimta Labs Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Vimta Labs Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Vimta Labs Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.
2. Does Vimta Labs Ltd pay dividends? ›
Yes, Vimta Labs Ltd has a consistent history of rewarding its shareholders through dividend payouts. Dividend frequency and amounts vary depending on the company’s financial performance and board approvals. Investors holding Vimta Labs Ltd shares on the record date announced by the company are eligible to receive dividends directly into their bank accounts linked with their Demat holdings.
3. What is the current share price of Vimta Labs Ltd ? ›
As of
06-11-2025 the share price for Vimta Labs Ltd. is 621.9 on the NSE (Note: Prices are dynamic and update frequently during market hours).
4. What is the 52-week high and low of Vimta Labs Ltd ? ›
The 52-week high and low of Vimta Labs Ltd share price is ₹ 285.05 - ₹ 902.65 as of
06-11-2025 .
PL Ringside View
Our fireside chat series where industry experts and top management share valuable insights for our clients
